BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 5008439)

  • 1. Antibody-dependent lymphoid cell-mediated cytotoxicity: no requirement for thymus-derived lymphocytes.
    Van Boxel JA; Stobo JD; Paul WE; Green I
    Science; 1972 Jan; 175(4018):194-6. PubMed ID: 5008439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-to-cell interaction in the immune response. VII. Requirement for differentiation of thymus-derived cells.
    Miller JF; Sprent J; Basten A; Warner NL; Breitner JC; Rowland G; Hamilton J; Silver H; Martin WJ
    J Exp Med; 1971 Nov; 134(5):1266-84. PubMed ID: 5165203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The alternate complement pathway in cell damage: antibody-mediated cytolysis of erythrocytes and nucleated cells.
    May JE; Green I; Frank MM
    J Immunol; 1972 Sep; 109(3):595-601. PubMed ID: 4115545
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of antilymphocyte serum on the thymus.
    Levey RH; Taub R
    Transplant Proc; 1969 Mar; 1(1):424-8. PubMed ID: 4944253
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-theta antibodies for detecting thymus-dependent lymphocytes in the immune response of mice to SRBC.
    Schlesinger M
    Nature; 1970 Jun; 226(5252):1254-6. PubMed ID: 4912322
    [No Abstract]   [Full Text] [Related]  

  • 6. Surface antigenic markers for distinguishing T and B lymphocytes in mice.
    Raff MC
    Transplant Rev; 1971; 6():52-80. PubMed ID: 4108877
    [No Abstract]   [Full Text] [Related]  

  • 7. Brain-associated theta antigen: reactivity of rabbit anti-mouse brain with mouse lymphoid cells.
    Golub ES
    Cell Immunol; 1971 Aug; 2(4):353-61. PubMed ID: 4399614
    [No Abstract]   [Full Text] [Related]  

  • 8. Cell interactions in humoral and cell-mediated immunity.
    Dennert G; Lennox E
    Nat New Biol; 1972 Jul; 238(82):114-6. PubMed ID: 4558265
    [No Abstract]   [Full Text] [Related]  

  • 9. Mode of action of antilymphocyte serum.
    Lance EM
    Fed Proc; 1970; 29(1):209-11. PubMed ID: 4904625
    [No Abstract]   [Full Text] [Related]  

  • 10. Specific in vitro cytotoxicity of thymus-derived lymphocytes sensitized to alloantigens.
    Cerottini JC; Nordin AA; Brunner KT
    Nature; 1970 Dec; 228(5278):1308-9. PubMed ID: 4922690
    [No Abstract]   [Full Text] [Related]  

  • 11. Ability of anti-brain heteroantisera to distinguish thymus-derived lymphocytes in various species.
    Kongshavn PA; Gold P; Shuster J; Colquhoun B; Freedman SO
    Clin Immunol Immunopathol; 1974 Sep; 3(1):1-15. PubMed ID: 4548010
    [No Abstract]   [Full Text] [Related]  

  • 12. Rosette formation by guinea pig thymocytes and thymus derived lymphocytes with rabbit red blood cells.
    Stadecker MJ; Bishop G; Wortis HH
    J Immunol; 1973 Dec; 111(6):1834-7. PubMed ID: 4201559
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody-mediated target cell lysis by non-immune cells. Characterization of the antibody and effector cell populations.
    Gelfand EW; Resch K; Prester M
    Eur J Immunol; 1972 Oct; 2(5):419-24. PubMed ID: 5084393
    [No Abstract]   [Full Text] [Related]  

  • 14. Specific inactivation of thymus-derived (T) and non-thymus-derived (B) lymphocytes by 125I-labelled antigen.
    Basten A; Miller JF; Warner NL; Pye J
    Nat New Biol; 1971 May; 231(21):104-6. PubMed ID: 4103326
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell-mediated immune response in vitro. II. The role of thymus and thymus-derived lymphocytes.
    Wagner H; Harris AW; Feldmann M
    Cell Immunol; 1972 May; 4(1):39-50. PubMed ID: 4401545
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphocyte subpopulations in NZB mice: deficit of thymus-dependent lymphocytes.
    Stutman O
    J Immunol; 1972 Sep; 109(3):602-11. PubMed ID: 4538300
    [No Abstract]   [Full Text] [Related]  

  • 17. An antigenic marker for human thymic lymphocytes.
    Smith RW; Terry WD; Buell DN; Sell KW
    J Immunol; 1973 Mar; 110(3):884-7. PubMed ID: 4540134
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of heterologous anti-lymphocyte serum on lymphocytes of thymus and marrow origin.
    Jeejeebhoy HF
    J Exp Med; 1970 Nov; 132(5):963-75. PubMed ID: 5470511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The heterocytotoxicity of human serum. I. Activation of the alternative complement pathway by heterologous target cells.
    Eidinger D; Bello E; Mates A
    Cell Immunol; 1977 Mar; 29(1):174-86. PubMed ID: 403014
    [No Abstract]   [Full Text] [Related]  

  • 20. The correlation between the proliferative and the cytotoxic responses of mouse lymphocytes to allogeneic cells in vitro.
    Wagner H
    J Immunol; 1972 Sep; 109(3):630-7. PubMed ID: 5055183
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.